What we promise?
Product | 2-Hydroxy Atorvastatin D5 Calcium Salt |
---|---|
CAT No. | CS-O-00659 |
CAS No. | 265989-46-6(Unlabeled) |
Status | Available for Dispatch by 24-Sep-2023 |
Category | Stable Isotopes |
Mol. Wt. | 1197.40 mol/g |
Mol. For. | C₆₆H₅₈D₁₀CaF₂N₄O₁₂ |
Hazardous |
![]() |
2-Hydroxy Atorvastatin D5 Calcium Salt is a chemical compound that belongs to the class of statins, which are drugs used to lower cholesterol levels in the body. This compound is a deuterated derivative of atorvastatin calcium and contains five deuterium atoms. It is also known as (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt. The usage of 2-Hydroxy Atorvastatin D5 Calcium Salt is primarily for research and analytical purposes. It is used as a reference standard in the development and validation of analytical methods for the quantification of atorvastatin in biological samples. It is also used in the study of the pharmacokinetics and metabolism of atorvastatin in the body. The chemical information of this compound includes its molecular weight, which is 1207.22 g/mol, and its molecular formula, which is C66H73D5CaFNO13. It is a white to off-white powder that is soluble in water and ethanol. The compound is stable under normal storage conditions and can be stored at room temperature. However, it should be protected from light and moisture to prevent degradation. In conclusion, 2-Hydroxy Atorvastatin D5 Calcium Salt is a useful tool for researchers studying atorvastatin metabolism and pharmacokinetics. Its high purity and stability make it an ideal reference standard for the development of analytical methods for atorvastatin quantification.
Packing | Product will be supplied in Vials, in certain conditions we also use 'Septa Vials' |
---|---|
Controlled | No |
Parent API | Atorvastatin |
Purity | Not less than 90% |
Therapeutic | Anti-Diabetic |
Isotopic Enrichment | Not less than 95% |
Canonical Smiles | CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4O.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4O.[Ca+2] |
InchIKey | NOCWNJZXNVSDOU-UHFFFAOYSA-L |
Inchl | InChI=1S/2C33H35FN2O6.Ca/c2*1-20(2)31-30(33(42)35-26-10-6-7-11-27(26)39)29(21-8-4-3-5-9-21)32(22-12-14-23(34)15-13-22)36(31)17-16-24(37)18-25(38)19-28(40)41;/h2*3-15,20,24-25,37-39H,16-19H2,1-2H3,(H,35,42)(H,40,41);/q;;+2/p-2 |
IUPAC | calcium;7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-3-phenyl-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate |
Hazardous | Yes |
General Information | Use proper personal protective equipment |
---|---|
Handling | Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. |
Engineering Control | Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels. |
Clothing | Wear appropriate protective clothing to minimize contact with skin. |
Skin | Wear appropriate protective gloves and clothing to prevent skin exposure. |
Eyes | Wear safety glasses and chemical goggles if splashing is possible. |
Inhalation | Remove from exposure and move to fresh air immediately. |
![]() |
2-Hydroxy Atorvastat... | www.clearsynth.com |
CAT : CS-O-00659 | BATCH : CSC-WWW0757 |
|
MF: C₆₆H₅₈D₁₀CaF₂N₄O₁₂ CAS: 265989-46-6(Unlabeled) Date of Anaysis: 19-Aug-2023 Retest Date: 19-Jun-2026 |
MW: 1197.40
Store at refrigerator (2-8C) |
Qty: 60 MG |
Only for R & D and Analytical purpose, Not for Human Consumption. |
Impurities
Impurities
API Standards
API Standards
Impurities
Impurities
Impurities
Impurities
Intermediates
Metabolites
Impurities
Impurities
Impurities
Glucuronides
Impurities
Impurities
API Standards
EP Standards
API Standards
Secondary Standards
Impurities
Impurities
Impurities
Stable Isotopes
Stable Isotopes
Stable Isotopes
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Need a Quote?
Your email address will not be published. Required fields are marked *